BIOMAT Database Logo BIOMAT Database Logo

[Does bromocriptine enhance the effect of drugs that reduce intraocular pressure?]. 1983

A Lustig

UI MeSH Term Description Entries
D007429 Intraocular Pressure The pressure of the fluids in the eye. Ocular Tension,Intraocular Pressures,Ocular Tensions,Pressure, Intraocular,Pressures, Intraocular,Tension, Ocular,Tensions, Ocular
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Lustig
Effect of oral bromocriptine on intraocular pressure.
August 1996, Journal of glaucoma,
A Lustig
[Does Catapresan reduce the intraocular pressure independently from blood pressure?].
November 1971, Klinische Monatsblatter fur Augenheilkunde,
A Lustig
The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma.
January 2020, Journal of experimental pharmacology,
A Lustig
Bromocriptine lowers intraocular pressure without affecting blood pressure.
June 1983, Lancet (London, England),
A Lustig
Deliberate arterial hypotension does not reduce intraocular pressure in pigs.
September 1992, Anesthesiology,
A Lustig
Effect os systemic drugs on intraocular pressure.
February 1969, Journal of the Iowa Medical Society,
A Lustig
The effects of dopamine, haloperidol and bromocriptine on intraocular pressure.
September 1992, International ophthalmology,
A Lustig
The influence of drugs that change blood pressure on intraocular pressure in the anaesthetized rat.
January 1971, Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology,
A Lustig
Effect of oral bromocriptine administration on intraocular pressure in normotensive and glaucomatous human subjects.
December 1995, Journal of glaucoma,
A Lustig
[DRUGS LOWERING INTRAOCULAR PRESSURE].
October 1963, [Sogo rinsho] Clinic all-round,
Copied contents to your clipboard!